The regulation of insulin and glucose homeostasis by 26RFa and adropin has been heavily reported [191,192,193,194], and so abnormal control of insulin release by neuropeptides may play a central role in the dysfunction of metabolic regulation and energy homeostasis in obesity, as well as in the onset of cognitive decline observed in AD patients. This evidence concerns the gene INS and Mental deterioration.